Global Primary Sclerosing Cholangitis (PSC) Market Set to Flourish, Predicted to Reach USD 314.26 Million by 2033
The global primary sclerosing cholangitis (PSC) market is on the brink of substantial growth, poised to attain a valuation of USD 314.26 million by 2033, [read full press release…]